Todd Willcox
Plastic and Reconstructive Surgery Tacoma, WA Medical Doctor
NPI 1417931007 CMS profile 336030
5005 Main St Ste 125, Ste 125, Tacoma, WA 98407
General payments
$57
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Todd Willcox of Tacoma, WA is reported in the CMS Open Payments database as having received $57 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 4th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $44 | 1 | |
| 2022 | General | $13 | 1 |
Beside peers
- Todd Willcox
- Plastic and Reconstructive Surgery median
- Middle half of Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Todd Willcox were reported at $0. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.
Show as a table
| Year | Todd Willcox | Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $335 | $121–$1,264 | $163 |
| 2020 | $0 | $162 | $57–$417 | $114 |
| 2021 | $0 | $245 | $89–$735 | $132 |
| 2022 | $13 | $325 | $120–$932 | $149 |
| 2023 | $44 | $343 | $129–$999 | $160 |
| 2024 | $0 | $390 | $141–$1,085 | $164 |
| 2025 | $0 | $442 | $150–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
16
Drug cost
$171
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ondansetron Odt Ondansetron | Brand | 16 | $171 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 18 billing codesPaid by Medicare
$38,956
Medicare patients
63
Services billed
111
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 67% | |
| Cancer | 59% | |
| Arthritis | 41% | |
| Depression | 29% | |
| Diabetes | 22% | |
| Osteoporosis | 17% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Plastic and Reconstructive Surgery in Washington
Vincent Muoneke
Plastic and Reconstructive Surgery · Burien, WA
Fredric Stern
Plastic and Reconstructive Surgery · Bellevue, WA
Srinivas Susarla
Plastic and Reconstructive Surgery · Seattle, WA
Kristin Tarbet
Plastic and Reconstructive Surgery · Bellevue, WA
Javad Sajan
Plastic and Reconstructive Surgery · Seattle, WA
Sepehr Egrari
Plastic and Reconstructive Surgery · Bellevue, WA
Related records
Plastic and Reconstructive Surgery in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.